Literature DB >> 9342341

Human deoxycytidine kinase is located in the cell nucleus.

M Johansson1, S Brismar, A Karlsson.   

Abstract

Human deoxyribonucleoside kinases are required for the pharmacological activity of several clinically important anticancer and antiviral nucleoside analogs. Human deoxycytidine kinase and thymidine kinase 1 are described as cytosolic enzymes in the literature, whereas human deoxyguanosine kinase and thymidine kinase 2 are believed to be located in the mitochondria. We expressed the four human deoxyribonucleoside kinases as fusion proteins with the green fluorescent protein to study their intracellular locations in vivo. Our data showed that the human deoxycytidine kinase is located in the cell nucleus and the human deoxyguanosine kinase is located in the mitochondria. The fusion proteins between green fluorescent protein and thymidine kinases 1 and 2 were both predominantly located in the cytosol. Site-directed mutagenesis of a putative nuclear targeting signal, identified in the primary structure of deoxycytidine kinase, completely abolished nuclear import of the protein. Reconstitution of a deoxycytidine kinase-deficient cell line with the wild-type nuclear or the mutant cytosolic enzymes both restored sensitivity toward anticancer nucleoside analogs. This paper reports that a deoxyribonucleoside kinase is located in the cell nucleus and we discuss the implications for deoxyribonucleotide synthesis and phosphorylation of nucleoside analogs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9342341      PMCID: PMC23663          DOI: 10.1073/pnas.94.22.11941

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Deoxyguanosine kinase. Distinct molecular forms in mitochondria and cytosol.

Authors:  W R Gower; M C Carr; D H Ives
Journal:  J Biol Chem       Date:  1979-04-10       Impact factor: 5.157

2.  Human cytosolic thymidine kinase. Purification and physical characterization of the enzyme from HeLa cells.

Authors:  J L Sherley; T J Kelly
Journal:  J Biol Chem       Date:  1988-01-05       Impact factor: 5.157

3.  A genetically distinct thymidine kinase in mammalian mitochondria. Exclusive labeling of mitochondrial deoxyribonucleic acid.

Authors:  A J Berk; D A Clayton
Journal:  J Biol Chem       Date:  1973-04-25       Impact factor: 5.157

4.  Metabolism of 9-beta-D-xylofuranosyladenine by the Chinese hamster ovary cell.

Authors:  B A Harris; P P Saunders; W Plunkett
Journal:  Mol Pharmacol       Date:  1981-07       Impact factor: 4.436

5.  Multienzyme complex for metabolic channeling in mammalian DNA replication.

Authors:  G Prem veer Reddy; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

6.  Location and properties of two isoenzymes of cardiac adenylate kinase.

Authors:  E J Walker; J W Dow
Journal:  Biochem J       Date:  1982-05-01       Impact factor: 3.857

7.  Human thymidine kinase gene: molecular cloning and nucleotide sequence of a cDNA expressible in mammalian cells.

Authors:  H D Bradshaw; P L Deininger
Journal:  Mol Cell Biol       Date:  1984-11       Impact factor: 4.272

8.  Selective expansion of mitochondrial nucleoside triphosphate pools in antimetabolite-treated HeLa cells.

Authors:  R K Bestwick; G L Moffett; C K Mathews
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

9.  DNA precursor pools and ribonucleotide reductase activity: distribution between the nucleus and cytoplasm of mammalian cells.

Authors:  J M Leeds; M B Slabaugh; C K Mathews
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

10.  Immunocytochemical evidence for the cytoplasmic localization and differential expression during the cell cycle of the M1 and M2 subunits of mammalian ribonucleotide reductase.

Authors:  Y Engström; B Rozell
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

View more
  10 in total

1.  Novel nuclear hENT2 isoforms regulate cell cycle progression via controlling nucleoside transport and nuclear reservoir.

Authors:  Natalia Grañé-Boladeras; Christopher M Spring; W J Brad Hanna; Marçal Pastor-Anglada; Imogen R Coe
Journal:  Cell Mol Life Sci       Date:  2016-06-06       Impact factor: 9.261

2.  A new pyrimidine-specific reporter gene: a mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs.

Authors:  Yury Likar; Juan Zurita; Konstantin Dobrenkov; Larissa Shenker; Shangde Cai; Anton Neschadim; Jeffrey A Medin; Michel Sadelain; Hedvig Hricak; Vladimir Ponomarev
Journal:  J Nucl Med       Date:  2010-09       Impact factor: 10.057

3.  Immunocytochemical detection of deoxycytidine kinase in haematological malignancies and solid tumours.

Authors:  I Hubeek; G J Peters; A J F Broekhuizen; I Talianidis; J Sigmond; B E S Gibson; U Creutzig; G Giaccone; G J L Kaspers
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

4.  Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation.

Authors:  J Scott Brockenbrough; Janice K Morihara; Stephen E Hawes; Joshua E Stern; Janet S Rasey; Linda W Wiens; Qinghua Feng; Hubert Vesselle
Journal:  J Histochem Cytochem       Date:  2009-08-03       Impact factor: 2.479

5.  Differential intracellular compartmentalization of herpetic thymidine kinases (TKs) in TK gene-transfected tumor cells: molecular characterization of the nuclear localization signal of herpes simplex virus type 1 TK.

Authors:  B Degrève; M Johansson; E De Clercq; A Karlsson; J Balzarini
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

6.  Mimicking phosphorylation of Ser-74 on human deoxycytidine kinase selectively increases catalytic activity for dC and dC analogues.

Authors:  Theresa McSorley; Stephan Ort; Saugata Hazra; Arnon Lavie; Manfred Konrad
Journal:  FEBS Lett       Date:  2008-02-05       Impact factor: 4.124

7.  Mitochondrial basis for immune deficiency. Evidence from purine nucleoside phosphorylase-deficient mice.

Authors:  E Arpaia; P Benveniste; A Di Cristofano; Y Gu; I Dalal; S Kelly; M Hershfield; P P Pandolfi; C M Roifman; A Cohen
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

8.  dCK Expression and Gene Polymorphism With Gemcitabine Chemosensitivity in Patients With Pancreatic Ductal Adenocarcinoma: A Strobe-Compliant Observational Study.

Authors:  Junjie Xiong; Kiran Altaf; Nengwen Ke; Yichao Wang; Jie Tang; Chunlu Tan; Ang Li; Hao Zhang; Du He; Xubao Liu
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 9.  New insights into the synergism of nucleoside analogs with radiotherapy.

Authors:  Michael W Lee; William B Parker; Bo Xu
Journal:  Radiat Oncol       Date:  2013-09-26       Impact factor: 3.481

Review 10.  Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases.

Authors:  An R Van Rompay; Magnus Johansson; Anna Karlsson
Journal:  Pharmacol Ther       Date:  2003-11       Impact factor: 12.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.